Potential of germanium-based compounds in coronavirus infection Cover

.blurhash-client-img { display: none !important; }

Potential of germanium-based compounds in coronavirus infection

Acta Pharmaceutica

Volume 72 (2022): Issue 2 (June 2022)

By: VIOLETTA NAROKHA, IRYNA NIZHENKOVSKA and OLENA KUZNETSOVA

Open Access

|Dec 2021

Authors

VIOLETTA NAROKHA

v.narokha@ukr.net

Department of Pharmaceutical Biological and Toxicological Chemistry Faculty of Pharmacy, Bogomolets National Medical University, Kyiv, Ukraine

IRYNA NIZHENKOVSKA

Department of Pharmaceutical Biological and Toxicological Chemistry Faculty of Pharmacy, Bogomolets National Medical University, Kyiv, Ukraine

OLENA KUZNETSOVA

Department of Pharmaceutical Biological and Toxicological Chemistry Faculty of Pharmacy, Bogomolets National Medical University, Kyiv, Ukraine

DOI: https://doi.org/10.2478/acph-2022-0016 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 245 - 258

Accepted on: May 18, 2021

Published on: Dec 30, 2021

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

organic germanium,

Related subjects:

Pharmacy, other

© 2021 VIOLETTA NAROKHA, IRYNA NIZHENKOVSKA, OLENA KUZNETSOVA, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 72 (2022): Issue 2 (June 2022)Next article